Glaxo Downplayed Early Warning About AIDS Drug
Pharmalot (Free subscription) | 12/05/2008
At issue is the risk of heart attacks that may be associated with its Ziagen med. Regulators recently began reviewing safety data after publication of a large observational study of more than 33,300 HIV patients, who are being followed to evaluate short- and long-term adverse effects of AIDS drugs. However, Glaxo was officially told of the possible risk in May 2005, three years before it issued a...
